Algo version: 0.98b
Advanced Oncotherapy PLC is listed at the LSE Exchange
Advanced Oncotherapy PLC [AVO.L]
LSE Sector: Industry:Health Care Equipment & Services

Is Advanced Oncotherapy PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Advanced Oncotherapy PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP39.50, you would have made a loss of GBP-39.48 per share or -99.95%

No, the average daily trading liquidity for Advanced Oncotherapy PLC is GBP543 970 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Advanced Oncotherapy PLC has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Advanced Oncotherapy PLC to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.